nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—UGT1A8—Mycophenolate mofetil—systemic lupus erythematosus	0.182	0.545	CbGbCtD
Diflunisal—osteoarthritis—Prednisone—systemic lupus erythematosus	0.176	0.5	CpDpCtD
Diflunisal—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.176	0.5	CpDpCtD
Diflunisal—PTGS2—systemic lupus erythematosus	0.119	0.529	CbGaD
Diflunisal—ALB—systemic lupus erythematosus	0.106	0.471	CbGaD
Diflunisal—PTGS2—Dapsone—systemic lupus erythematosus	0.026	0.078	CbGbCtD
Diflunisal—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0225	0.0676	CbGbCtD
Diflunisal—PTGS1—Dapsone—systemic lupus erythematosus	0.0219	0.0658	CbGbCtD
Diflunisal—PTGS2—Betamethasone—systemic lupus erythematosus	0.0193	0.058	CbGbCtD
Diflunisal—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0142	0.0426	CbGbCtD
Diflunisal—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0126	0.0379	CbGbCtD
Diflunisal—TTR—choroid plexus—systemic lupus erythematosus	0.0124	0.389	CbGeAlD
Diflunisal—ALB—Prednisone—systemic lupus erythematosus	0.0114	0.0341	CbGbCtD
Diflunisal—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0112	0.0337	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00669	0.0201	CbGbCtD
Diflunisal—ALB—Methotrexate—systemic lupus erythematosus	0.0057	0.0171	CbGbCtD
Diflunisal—TTR—urine—systemic lupus erythematosus	0.00332	0.104	CbGeAlD
Diflunisal—TTR—blood plasma—systemic lupus erythematosus	0.00173	0.0544	CbGeAlD
Diflunisal—UGT1A8—kidney—systemic lupus erythematosus	0.00171	0.0537	CbGeAlD
Diflunisal—TTR—connective tissue—systemic lupus erythematosus	0.000924	0.0289	CbGeAlD
Diflunisal—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000916	0.0287	CbGeAlD
Diflunisal—Olsalazine—IFNG—systemic lupus erythematosus	0.00091	0.346	CrCbGaD
Diflunisal—TTR—kidney—systemic lupus erythematosus	0.000786	0.0246	CbGeAlD
Diflunisal—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000784	0.0246	CbGeAlD
Diflunisal—PTGS1—endothelium—systemic lupus erythematosus	0.00071	0.0223	CbGeAlD
Diflunisal—PTGS2—endothelium—systemic lupus erythematosus	0.000679	0.0213	CbGeAlD
Diflunisal—TTR—lymphoid tissue—systemic lupus erythematosus	0.000675	0.0212	CbGeAlD
Diflunisal—PTGS1—blood plasma—systemic lupus erythematosus	0.000631	0.0198	CbGeAlD
Diflunisal—TTR—bone marrow—systemic lupus erythematosus	0.000615	0.0193	CbGeAlD
Diflunisal—PTGS2—blood plasma—systemic lupus erythematosus	0.000603	0.0189	CbGeAlD
Diflunisal—TTR—lung—systemic lupus erythematosus	0.000557	0.0175	CbGeAlD
Diflunisal—TTR—nervous system—systemic lupus erythematosus	0.000516	0.0162	CbGeAlD
Diflunisal—TTR—central nervous system—systemic lupus erythematosus	0.000497	0.0156	CbGeAlD
Diflunisal—Olsalazine—PPARG—systemic lupus erythematosus	0.000429	0.163	CrCbGaD
Diflunisal—PTGS1—connective tissue—systemic lupus erythematosus	0.000336	0.0105	CbGeAlD
Diflunisal—PTGS2—connective tissue—systemic lupus erythematosus	0.000321	0.0101	CbGeAlD
Diflunisal—Mesalazine—PPARG—systemic lupus erythematosus	0.000316	0.12	CrCbGaD
Diflunisal—PTGS1—skin of body—systemic lupus erythematosus	0.000303	0.0095	CbGeAlD
Diflunisal—PTGS2—skin of body—systemic lupus erythematosus	0.00029	0.00908	CbGeAlD
Diflunisal—PTGS1—kidney—systemic lupus erythematosus	0.000286	0.00896	CbGeAlD
Diflunisal—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000276	0.159	CbGdCrCtD
Diflunisal—PTGS2—kidney—systemic lupus erythematosus	0.000273	0.00856	CbGeAlD
Diflunisal—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000271	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000271	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000265	0.153	CbGdCrCtD
Diflunisal—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000235	0.00736	CbGeAlD
Diflunisal—PTGS1—tendon—systemic lupus erythematosus	0.000231	0.00723	CbGeAlD
Diflunisal—PTGS2—tendon—systemic lupus erythematosus	0.000221	0.00692	CbGeAlD
Diflunisal—PTGS2—bone marrow—systemic lupus erythematosus	0.000214	0.0067	CbGeAlD
Diflunisal—PTGS1—lung—systemic lupus erythematosus	0.000203	0.00635	CbGeAlD
Diflunisal—PTGS2—lung—systemic lupus erythematosus	0.000194	0.00607	CbGeAlD
Diflunisal—PTGS1—nervous system—systemic lupus erythematosus	0.000188	0.00588	CbGeAlD
Diflunisal—Olsalazine—PTGS2—systemic lupus erythematosus	0.000181	0.0688	CrCbGaD
Diflunisal—PTGS1—central nervous system—systemic lupus erythematosus	0.000181	0.00566	CbGeAlD
Diflunisal—PTGS2—nervous system—systemic lupus erythematosus	0.000179	0.00562	CbGeAlD
Diflunisal—PTGS2—central nervous system—systemic lupus erythematosus	0.000173	0.00541	CbGeAlD
Diflunisal—Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.00017	0.0647	CrCbGaD
Diflunisal—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000166	0.0957	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000164	0.0942	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000164	0.0942	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.00016	0.0921	CbGdCrCtD
Diflunisal—Salsalate—PTGS2—systemic lupus erythematosus	0.000154	0.0585	CrCbGaD
Diflunisal—Mesalazine—PTGS2—systemic lupus erythematosus	0.000133	0.0508	CrCbGaD
Diflunisal—Salicylic acid—PTGS2—systemic lupus erythematosus	9.46e-05	0.036	CrCbGaD
Diflunisal—Dyspepsia—Cyclosporine—systemic lupus erythematosus	8.65e-05	0.00179	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	8.65e-05	0.00179	CcSEcCtD
Diflunisal—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	8.61e-05	0.00178	CcSEcCtD
Diflunisal—Shock—Hydrocortisone—systemic lupus erythematosus	8.6e-05	0.00178	CcSEcCtD
Diflunisal—Vomiting—Azathioprine—systemic lupus erythematosus	8.58e-05	0.00177	CcSEcCtD
Diflunisal—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	8.55e-05	0.00177	CcSEcCtD
Diflunisal—Decreased appetite—Cyclosporine—systemic lupus erythematosus	8.55e-05	0.00177	CcSEcCtD
Diflunisal—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	8.53e-05	0.00176	CcSEcCtD
Diflunisal—Rash—Azathioprine—systemic lupus erythematosus	8.51e-05	0.00176	CcSEcCtD
Diflunisal—Dermatitis—Azathioprine—systemic lupus erythematosus	8.5e-05	0.00176	CcSEcCtD
Diflunisal—Flushing—Prednisone—systemic lupus erythematosus	8.49e-05	0.00175	CcSEcCtD
Diflunisal—Fatigue—Cyclosporine—systemic lupus erythematosus	8.48e-05	0.00175	CcSEcCtD
Diflunisal—Headache—Azathioprine—systemic lupus erythematosus	8.45e-05	0.00175	CcSEcCtD
Diflunisal—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	8.45e-05	0.00175	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	8.45e-05	0.00175	CcSEcCtD
Diflunisal—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	8.44e-05	0.00174	CcSEcCtD
Diflunisal—Salicylic acid—ALB—systemic lupus erythematosus	8.43e-05	0.0321	CrCbGaD
Diflunisal—Dizziness—Leflunomide—systemic lupus erythematosus	8.42e-05	0.00174	CcSEcCtD
Diflunisal—Constipation—Cyclosporine—systemic lupus erythematosus	8.41e-05	0.00174	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—systemic lupus erythematosus	8.37e-05	0.00173	CcSEcCtD
Diflunisal—Angioedema—Dexamethasone—systemic lupus erythematosus	8.36e-05	0.00173	CcSEcCtD
Diflunisal—Angioedema—Betamethasone—systemic lupus erythematosus	8.36e-05	0.00173	CcSEcCtD
Diflunisal—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	8.34e-05	0.00172	CcSEcCtD
Diflunisal—Anorexia—Hydrocortisone—systemic lupus erythematosus	8.33e-05	0.00172	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—systemic lupus erythematosus	8.3e-05	0.00172	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—systemic lupus erythematosus	8.3e-05	0.0316	CrCbGaD
Diflunisal—Confusional state—Methylprednisolone—systemic lupus erythematosus	8.28e-05	0.00171	CcSEcCtD
Diflunisal—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	8.23e-05	0.0017	CcSEcCtD
Diflunisal—Oedema—Triamcinolone—systemic lupus erythematosus	8.23e-05	0.0017	CcSEcCtD
Diflunisal—Vertigo—Dexamethasone—systemic lupus erythematosus	8.22e-05	0.0017	CcSEcCtD
Diflunisal—Vertigo—Betamethasone—systemic lupus erythematosus	8.22e-05	0.0017	CcSEcCtD
Diflunisal—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	8.21e-05	0.0017	CcSEcCtD
Diflunisal—Syncope—Betamethasone—systemic lupus erythematosus	8.2e-05	0.0017	CcSEcCtD
Diflunisal—Syncope—Dexamethasone—systemic lupus erythematosus	8.2e-05	0.0017	CcSEcCtD
Diflunisal—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	8.2e-05	0.00169	CcSEcCtD
Diflunisal—Sweating—Methotrexate—systemic lupus erythematosus	8.17e-05	0.00169	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—systemic lupus erythematosus	8.12e-05	0.00168	CcSEcCtD
Diflunisal—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	8.1e-05	0.00167	CcSEcCtD
Diflunisal—Vomiting—Leflunomide—systemic lupus erythematosus	8.1e-05	0.00167	CcSEcCtD
Diflunisal—Shock—Triamcinolone—systemic lupus erythematosus	8.09e-05	0.00167	CcSEcCtD
Diflunisal—Insomnia—Prednisolone—systemic lupus erythematosus	8.09e-05	0.00167	CcSEcCtD
Diflunisal—Shock—Methylprednisolone—systemic lupus erythematosus	8.08e-05	0.00167	CcSEcCtD
Diflunisal—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	8.04e-05	0.00166	CcSEcCtD
Diflunisal—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	8.04e-05	0.00166	CcSEcCtD
Diflunisal—Loss of consciousness—Betamethasone—systemic lupus erythematosus	8.04e-05	0.00166	CcSEcCtD
Diflunisal—Paraesthesia—Prednisolone—systemic lupus erythematosus	8.03e-05	0.00166	CcSEcCtD
Diflunisal—Rash—Leflunomide—systemic lupus erythematosus	8.03e-05	0.00166	CcSEcCtD
Diflunisal—Dermatitis—Leflunomide—systemic lupus erythematosus	8.02e-05	0.00166	CcSEcCtD
Diflunisal—Nausea—Azathioprine—systemic lupus erythematosus	8.01e-05	0.00166	CcSEcCtD
Diflunisal—Headache—Leflunomide—systemic lupus erythematosus	7.98e-05	0.00165	CcSEcCtD
Diflunisal—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	7.95e-05	0.00164	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—systemic lupus erythematosus	7.95e-05	0.00164	CcSEcCtD
Diflunisal—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	7.94e-05	0.00164	CcSEcCtD
Diflunisal—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	7.9e-05	0.00163	CcSEcCtD
Diflunisal—Insomnia—Hydrocortisone—systemic lupus erythematosus	7.9e-05	0.00163	CcSEcCtD
Diflunisal—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	7.85e-05	0.00162	CcSEcCtD
Diflunisal—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	7.84e-05	0.00162	CcSEcCtD
Diflunisal—Urticaria—Cyclosporine—systemic lupus erythematosus	7.81e-05	0.00161	CcSEcCtD
Diflunisal—Body temperature increased—Cyclosporine—systemic lupus erythematosus	7.77e-05	0.00161	CcSEcCtD
Diflunisal—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	7.69e-05	0.00159	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—systemic lupus erythematosus	7.65e-05	0.00158	CcSEcCtD
Diflunisal—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.62e-05	0.00157	CcSEcCtD
Diflunisal—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	7.6e-05	0.00157	CcSEcCtD
Diflunisal—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	7.58e-05	0.00157	CcSEcCtD
Diflunisal—Nausea—Leflunomide—systemic lupus erythematosus	7.57e-05	0.00156	CcSEcCtD
Diflunisal—Fatigue—Hydrocortisone—systemic lupus erythematosus	7.53e-05	0.00156	CcSEcCtD
Diflunisal—Vision blurred—Prednisone—systemic lupus erythematosus	7.51e-05	0.00155	CcSEcCtD
Diflunisal—Oedema—Betamethasone—systemic lupus erythematosus	7.46e-05	0.00154	CcSEcCtD
Diflunisal—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.46e-05	0.00154	CcSEcCtD
Diflunisal—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.46e-05	0.00154	CcSEcCtD
Diflunisal—Oedema—Dexamethasone—systemic lupus erythematosus	7.46e-05	0.00154	CcSEcCtD
Diflunisal—Insomnia—Triamcinolone—systemic lupus erythematosus	7.44e-05	0.00154	CcSEcCtD
Diflunisal—Insomnia—Methylprednisolone—systemic lupus erythematosus	7.42e-05	0.00153	CcSEcCtD
Diflunisal—Flurbiprofen—ALB—systemic lupus erythematosus	7.39e-05	0.0281	CrCbGaD
Diflunisal—Paraesthesia—Triamcinolone—systemic lupus erythematosus	7.39e-05	0.00153	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.37e-05	0.00152	CcSEcCtD
Diflunisal—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	7.37e-05	0.00152	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—systemic lupus erythematosus	7.37e-05	0.00152	CcSEcCtD
Diflunisal—Shock—Dexamethasone—systemic lupus erythematosus	7.34e-05	0.00152	CcSEcCtD
Diflunisal—Shock—Betamethasone—systemic lupus erythematosus	7.34e-05	0.00152	CcSEcCtD
Diflunisal—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.33e-05	0.00152	CcSEcCtD
Diflunisal—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	7.31e-05	0.00151	CcSEcCtD
Diflunisal—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	7.31e-05	0.00151	CcSEcCtD
Diflunisal—Angioedema—Prednisone—systemic lupus erythematosus	7.28e-05	0.0015	CcSEcCtD
Diflunisal—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.24e-05	0.0015	CcSEcCtD
Diflunisal—Dyspepsia—Triamcinolone—systemic lupus erythematosus	7.24e-05	0.0015	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—systemic lupus erythematosus	7.23e-05	0.00149	CcSEcCtD
Diflunisal—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	7.23e-05	0.00149	CcSEcCtD
Diflunisal—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	7.22e-05	0.00149	CcSEcCtD
Diflunisal—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	7.22e-05	0.00149	CcSEcCtD
Diflunisal—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	7.2e-05	0.00149	CcSEcCtD
Diflunisal—Vertigo—Prednisone—systemic lupus erythematosus	7.16e-05	0.00148	CcSEcCtD
Diflunisal—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	7.14e-05	0.00148	CcSEcCtD
Diflunisal—Syncope—Prednisone—systemic lupus erythematosus	7.14e-05	0.00148	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—systemic lupus erythematosus	7.13e-05	0.00147	CcSEcCtD
Diflunisal—Anorexia—Betamethasone—systemic lupus erythematosus	7.12e-05	0.00147	CcSEcCtD
Diflunisal—Anorexia—Dexamethasone—systemic lupus erythematosus	7.12e-05	0.00147	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—systemic lupus erythematosus	7.11e-05	0.00147	CcSEcCtD
Diflunisal—Fatigue—Triamcinolone—systemic lupus erythematosus	7.09e-05	0.00147	CcSEcCtD
Diflunisal—Fatigue—Methylprednisolone—systemic lupus erythematosus	7.08e-05	0.00146	CcSEcCtD
Diflunisal—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	7.07e-05	0.00146	CcSEcCtD
Diflunisal—Asthenia—Cyclosporine—systemic lupus erythematosus	7.05e-05	0.00146	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisone—systemic lupus erythematosus	7e-05	0.00145	CcSEcCtD
Diflunisal—Pruritus—Cyclosporine—systemic lupus erythematosus	6.96e-05	0.00144	CcSEcCtD
Diflunisal—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.94e-05	0.00143	CcSEcCtD
Diflunisal—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	6.91e-05	0.00143	CcSEcCtD
Diflunisal—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.88e-05	0.00142	CcSEcCtD
Diflunisal—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.79e-05	0.0014	CcSEcCtD
Diflunisal—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.78e-05	0.0014	CcSEcCtD
Diflunisal—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.76e-05	0.0014	CcSEcCtD
Diflunisal—Insomnia—Betamethasone—systemic lupus erythematosus	6.75e-05	0.0014	CcSEcCtD
Diflunisal—Insomnia—Dexamethasone—systemic lupus erythematosus	6.75e-05	0.0014	CcSEcCtD
Diflunisal—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.73e-05	0.00139	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.71e-05	0.00139	CcSEcCtD
Diflunisal—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.7e-05	0.00139	CcSEcCtD
Diflunisal—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.7e-05	0.00139	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.59e-05	0.00136	CcSEcCtD
Diflunisal—Dyspepsia—Betamethasone—systemic lupus erythematosus	6.57e-05	0.00136	CcSEcCtD
Diflunisal—Dyspepsia—Dexamethasone—systemic lupus erythematosus	6.57e-05	0.00136	CcSEcCtD
Diflunisal—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.56e-05	0.00136	CcSEcCtD
Diflunisal—Urticaria—Triamcinolone—systemic lupus erythematosus	6.54e-05	0.00135	CcSEcCtD
Diflunisal—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.52e-05	0.00135	CcSEcCtD
Diflunisal—Body temperature increased—Triamcinolone—systemic lupus erythematosus	6.5e-05	0.00134	CcSEcCtD
Diflunisal—Dizziness—Cyclosporine—systemic lupus erythematosus	6.5e-05	0.00134	CcSEcCtD
Diflunisal—Oedema—Prednisone—systemic lupus erythematosus	6.5e-05	0.00134	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.5e-05	0.00134	CcSEcCtD
Diflunisal—Decreased appetite—Dexamethasone—systemic lupus erythematosus	6.49e-05	0.00134	CcSEcCtD
Diflunisal—Decreased appetite—Betamethasone—systemic lupus erythematosus	6.49e-05	0.00134	CcSEcCtD
Diflunisal—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.44e-05	0.00133	CcSEcCtD
Diflunisal—Fatigue—Betamethasone—systemic lupus erythematosus	6.44e-05	0.00133	CcSEcCtD
Diflunisal—Fatigue—Dexamethasone—systemic lupus erythematosus	6.44e-05	0.00133	CcSEcCtD
Diflunisal—Shock—Prednisone—systemic lupus erythematosus	6.4e-05	0.00132	CcSEcCtD
Diflunisal—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.34e-05	0.00131	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisone—systemic lupus erythematosus	6.28e-05	0.0013	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—systemic lupus erythematosus	6.27e-05	0.0013	CcSEcCtD
Diflunisal—Asthenia—Hydrocortisone—systemic lupus erythematosus	6.27e-05	0.0013	CcSEcCtD
Diflunisal—Vomiting—Cyclosporine—systemic lupus erythematosus	6.25e-05	0.00129	CcSEcCtD
Diflunisal—Rash—Cyclosporine—systemic lupus erythematosus	6.2e-05	0.00128	CcSEcCtD
Diflunisal—Anorexia—Prednisone—systemic lupus erythematosus	6.2e-05	0.00128	CcSEcCtD
Diflunisal—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.19e-05	0.00128	CcSEcCtD
Diflunisal—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.18e-05	0.00128	CcSEcCtD
Diflunisal—Headache—Cyclosporine—systemic lupus erythematosus	6.16e-05	0.00127	CcSEcCtD
Diflunisal—Feeling abnormal—Betamethasone—systemic lupus erythematosus	6.15e-05	0.00127	CcSEcCtD
Diflunisal—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	6.15e-05	0.00127	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	6.1e-05	0.00126	CcSEcCtD
Diflunisal—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	6.1e-05	0.00126	CcSEcCtD
Diflunisal—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	6.1e-05	0.00126	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—ITGAM—systemic lupus erythematosus	6.09e-05	0.00926	CbGpPWpGaD
Diflunisal—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	6.06e-05	0.00125	CcSEcCtD
Diflunisal—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	6.05e-05	0.00125	CcSEcCtD
Diflunisal—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.05e-05	0.00125	CcSEcCtD
Diflunisal—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.04e-05	0.00125	CcSEcCtD
Diflunisal—Headache—Mycophenolate mofetil—systemic lupus erythematosus	6.01e-05	0.00124	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	6.01e-05	0.00913	CbGpPWpGaD
Diflunisal—Vertigo—Methotrexate—systemic lupus erythematosus	5.98e-05	0.00124	CcSEcCtD
Diflunisal—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.98e-05	0.00124	CcSEcCtD
Diflunisal—Urticaria—Dexamethasone—systemic lupus erythematosus	5.93e-05	0.00123	CcSEcCtD
Diflunisal—Urticaria—Betamethasone—systemic lupus erythematosus	5.93e-05	0.00123	CcSEcCtD
Diflunisal—Dizziness—Prednisolone—systemic lupus erythematosus	5.92e-05	0.00122	CcSEcCtD
Diflunisal—Asthenia—Triamcinolone—systemic lupus erythematosus	5.9e-05	0.00122	CcSEcCtD
Diflunisal—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.9e-05	0.00122	CcSEcCtD
Diflunisal—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.9e-05	0.00122	CcSEcCtD
Diflunisal—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.89e-05	0.00122	CcSEcCtD
Diflunisal—Insomnia—Prednisone—systemic lupus erythematosus	5.88e-05	0.00122	CcSEcCtD
Diflunisal—Nausea—Cyclosporine—systemic lupus erythematosus	5.84e-05	0.00121	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—systemic lupus erythematosus	5.84e-05	0.00121	CcSEcCtD
Diflunisal—Pruritus—Triamcinolone—systemic lupus erythematosus	5.82e-05	0.0012	CcSEcCtD
Diflunisal—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.81e-05	0.0012	CcSEcCtD
Diflunisal—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.78e-05	0.00119	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	5.74e-05	0.00873	CbGpPWpGaD
Diflunisal—Dyspepsia—Prednisone—systemic lupus erythematosus	5.72e-05	0.00118	CcSEcCtD
Diflunisal—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.7e-05	0.00118	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—systemic lupus erythematosus	5.67e-05	0.00117	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—systemic lupus erythematosus	5.65e-05	0.00117	CcSEcCtD
Diflunisal—Rash—Prednisolone—systemic lupus erythematosus	5.64e-05	0.00117	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—systemic lupus erythematosus	5.64e-05	0.00116	CcSEcCtD
Diflunisal—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.62e-05	0.00116	CcSEcCtD
Diflunisal—Fatigue—Prednisone—systemic lupus erythematosus	5.6e-05	0.00116	CcSEcCtD
Diflunisal—Headache—Prednisolone—systemic lupus erythematosus	5.6e-05	0.00116	CcSEcCtD
Diflunisal—Constipation—Prednisone—systemic lupus erythematosus	5.56e-05	0.00115	CcSEcCtD
Diflunisal—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.56e-05	0.00115	CcSEcCtD
Diflunisal—Rash—Hydrocortisone—systemic lupus erythematosus	5.51e-05	0.00114	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	5.5e-05	0.00837	CbGpPWpGaD
Diflunisal—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.5e-05	0.00114	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—systemic lupus erythematosus	5.48e-05	0.00113	CcSEcCtD
Diflunisal—Headache—Hydrocortisone—systemic lupus erythematosus	5.47e-05	0.00113	CcSEcCtD
Diflunisal—Dizziness—Triamcinolone—systemic lupus erythematosus	5.44e-05	0.00112	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.43e-05	0.00112	CcSEcCtD
Diflunisal—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.43e-05	0.00112	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.36e-05	0.00111	CcSEcCtD
Diflunisal—Asthenia—Betamethasone—systemic lupus erythematosus	5.36e-05	0.00111	CcSEcCtD
Diflunisal—Asthenia—Dexamethasone—systemic lupus erythematosus	5.36e-05	0.00111	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.32e-05	0.0011	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	5.32e-05	0.0011	CcSEcCtD
Diflunisal—Nausea—Prednisolone—systemic lupus erythematosus	5.31e-05	0.0011	CcSEcCtD
Diflunisal—Pruritus—Betamethasone—systemic lupus erythematosus	5.28e-05	0.00109	CcSEcCtD
Diflunisal—Pruritus—Dexamethasone—systemic lupus erythematosus	5.28e-05	0.00109	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	5.25e-05	0.00109	CcSEcCtD
Diflunisal—Vomiting—Triamcinolone—systemic lupus erythematosus	5.23e-05	0.00108	CcSEcCtD
Diflunisal—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.22e-05	0.00108	CcSEcCtD
Diflunisal—Nausea—Hydrocortisone—systemic lupus erythematosus	5.19e-05	0.00107	CcSEcCtD
Diflunisal—Rash—Triamcinolone—systemic lupus erythematosus	5.19e-05	0.00107	CcSEcCtD
Diflunisal—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.18e-05	0.00107	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—systemic lupus erythematosus	5.18e-05	0.00107	CcSEcCtD
Diflunisal—Rash—Methylprednisolone—systemic lupus erythematosus	5.18e-05	0.00107	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	5.17e-05	0.00786	CbGpPWpGaD
Diflunisal—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.17e-05	0.00107	CcSEcCtD
Diflunisal—Urticaria—Prednisone—systemic lupus erythematosus	5.16e-05	0.00107	CcSEcCtD
Diflunisal—Headache—Triamcinolone—systemic lupus erythematosus	5.15e-05	0.00107	CcSEcCtD
Diflunisal—Headache—Methylprednisolone—systemic lupus erythematosus	5.14e-05	0.00106	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—systemic lupus erythematosus	5.14e-05	0.00106	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	5.14e-05	0.00781	CbGpPWpGaD
Diflunisal—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.11e-05	0.00106	CcSEcCtD
Diflunisal—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.11e-05	0.00106	CcSEcCtD
Diflunisal—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	5.1e-05	0.00776	CbGpPWpGaD
Diflunisal—Dizziness—Dexamethasone—systemic lupus erythematosus	4.94e-05	0.00102	CcSEcCtD
Diflunisal—Dizziness—Betamethasone—systemic lupus erythematosus	4.94e-05	0.00102	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—systemic lupus erythematosus	4.91e-05	0.00102	CcSEcCtD
Diflunisal—Nausea—Triamcinolone—systemic lupus erythematosus	4.89e-05	0.00101	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.88e-05	0.00101	CcSEcCtD
Diflunisal—Nausea—Methylprednisolone—systemic lupus erythematosus	4.88e-05	0.00101	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.84e-05	0.001	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—systemic lupus erythematosus	4.83e-05	0.000998	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.79e-05	0.00099	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	4.79e-05	0.00727	CbGpPWpGaD
Diflunisal—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000988	CcSEcCtD
Diflunisal—ALB—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	4.77e-05	0.00725	CbGpPWpGaD
Diflunisal—Vomiting—Dexamethasone—systemic lupus erythematosus	4.75e-05	0.000981	CcSEcCtD
Diflunisal—Vomiting—Betamethasone—systemic lupus erythematosus	4.75e-05	0.000981	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000976	CcSEcCtD
Diflunisal—Rash—Dexamethasone—systemic lupus erythematosus	4.71e-05	0.000973	CcSEcCtD
Diflunisal—Rash—Betamethasone—systemic lupus erythematosus	4.71e-05	0.000973	CcSEcCtD
Diflunisal—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.7e-05	0.000972	CcSEcCtD
Diflunisal—Dermatitis—Betamethasone—systemic lupus erythematosus	4.7e-05	0.000972	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000968	CcSEcCtD
Diflunisal—Headache—Betamethasone—systemic lupus erythematosus	4.68e-05	0.000966	CcSEcCtD
Diflunisal—Headache—Dexamethasone—systemic lupus erythematosus	4.68e-05	0.000966	CcSEcCtD
Diflunisal—Asthenia—Prednisone—systemic lupus erythematosus	4.66e-05	0.000964	CcSEcCtD
Diflunisal—Pruritus—Prednisone—systemic lupus erythematosus	4.6e-05	0.00095	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—CLU—systemic lupus erythematosus	4.49e-05	0.00683	CbGpPWpGaD
Diflunisal—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000925	CcSEcCtD
Diflunisal—Diarrhoea—Prednisone—systemic lupus erythematosus	4.45e-05	0.000919	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.44e-05	0.000918	CcSEcCtD
Diflunisal—Nausea—Dexamethasone—systemic lupus erythematosus	4.43e-05	0.000916	CcSEcCtD
Diflunisal—Nausea—Betamethasone—systemic lupus erythematosus	4.43e-05	0.000916	CcSEcCtD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	4.41e-05	0.00671	CbGpPWpGaD
Diflunisal—Urticaria—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000892	CcSEcCtD
Diflunisal—Dizziness—Prednisone—systemic lupus erythematosus	4.3e-05	0.000888	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000888	CcSEcCtD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—CLU—systemic lupus erythematosus	4.28e-05	0.00651	CbGpPWpGaD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	4.27e-05	0.00649	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	4.24e-05	0.00645	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	4.15e-05	0.00631	CbGpPWpGaD
Diflunisal—Vomiting—Prednisone—systemic lupus erythematosus	4.13e-05	0.000854	CcSEcCtD
Diflunisal—Rash—Prednisone—systemic lupus erythematosus	4.1e-05	0.000847	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—systemic lupus erythematosus	4.1e-05	0.000846	CcSEcCtD
Diflunisal—Headache—Prednisone—systemic lupus erythematosus	4.07e-05	0.000842	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—systemic lupus erythematosus	4e-05	0.000827	CcSEcCtD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4e-05	0.00608	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	3.99e-05	0.00607	CbGpPWpGaD
Diflunisal—Asthenia—Methotrexate—systemic lupus erythematosus	3.9e-05	0.000806	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	3.89e-05	0.00591	CbGpPWpGaD
Diflunisal—Nausea—Prednisone—systemic lupus erythematosus	3.86e-05	0.000798	CcSEcCtD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	3.85e-05	0.00586	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	3.85e-05	0.00585	CbGpPWpGaD
Diflunisal—Pruritus—Methotrexate—systemic lupus erythematosus	3.84e-05	0.000794	CcSEcCtD
Diflunisal—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	3.79e-05	0.00576	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.77e-05	0.00573	CbGpPWpGaD
Diflunisal—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.72e-05	0.000768	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	3.71e-05	0.00564	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	3.63e-05	0.00552	CbGpPWpGaD
Diflunisal—Dizziness—Methotrexate—systemic lupus erythematosus	3.59e-05	0.000742	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	3.56e-05	0.00541	CbGpPWpGaD
Diflunisal—Vomiting—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000714	CcSEcCtD
Diflunisal—Rash—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000708	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000707	CcSEcCtD
Diflunisal—Headache—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000703	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.35e-05	0.00509	CbGpPWpGaD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	3.31e-05	0.00503	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	3.3e-05	0.00501	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	3.25e-05	0.00494	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	3.23e-05	0.00491	CbGpPWpGaD
Diflunisal—Nausea—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000667	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	2.86e-05	0.00435	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.84e-05	0.00431	CbGpPWpGaD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	2.78e-05	0.00422	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	2.76e-05	0.0042	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.69e-05	0.00409	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	2.67e-05	0.00406	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	2.66e-05	0.00404	CbGpPWpGaD
Diflunisal—TTR—Disease—XRCC6—systemic lupus erythematosus	2.6e-05	0.00394	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	2.52e-05	0.00383	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.48e-05	0.00378	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	2.47e-05	0.00375	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NAT2—systemic lupus erythematosus	2.46e-05	0.00374	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	2.35e-05	0.00357	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.28e-05	0.00347	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.21e-05	0.00336	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	2.2e-05	0.00334	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	2.18e-05	0.00331	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.14e-05	0.00325	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	2.13e-05	0.00323	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.1e-05	0.0032	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	2.09e-05	0.00317	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.06e-05	0.00314	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—F2—systemic lupus erythematosus	2.01e-05	0.00305	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2e-05	0.00304	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	1.99e-05	0.00303	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	1.97e-05	0.003	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	1.96e-05	0.00298	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	1.95e-05	0.00297	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	1.93e-05	0.00293	CbGpPWpGaD
Diflunisal—TTR—Disease—HIST2H2AC—systemic lupus erythematosus	1.91e-05	0.00291	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	1.9e-05	0.00288	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.88e-05	0.00286	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	1.88e-05	0.00285	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	1.87e-05	0.00284	CbGpPWpGaD
Diflunisal—TTR—Disease—CSK—systemic lupus erythematosus	1.86e-05	0.00283	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.8e-05	0.00274	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	1.79e-05	0.00272	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP9—systemic lupus erythematosus	1.78e-05	0.0027	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	1.78e-05	0.0027	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	1.77e-05	0.00269	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	1.76e-05	0.00267	CbGpPWpGaD
Diflunisal—TTR—Disease—CD247—systemic lupus erythematosus	1.75e-05	0.00266	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	1.73e-05	0.00263	CbGpPWpGaD
Diflunisal—TTR—Disease—NCF2—systemic lupus erythematosus	1.71e-05	0.00259	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	1.64e-05	0.00249	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.63e-05	0.00247	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	1.62e-05	0.00246	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	1.61e-05	0.00245	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	1.6e-05	0.00242	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.55e-05	0.00236	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	1.52e-05	0.00231	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	1.52e-05	0.00231	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	1.5e-05	0.00228	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.49e-05	0.00227	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TLR9—systemic lupus erythematosus	1.47e-05	0.00223	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	1.46e-05	0.00222	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	1.42e-05	0.00216	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.42e-05	0.00216	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.41e-05	0.00214	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.39e-05	0.00211	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—RXRA—systemic lupus erythematosus	1.38e-05	0.0021	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	1.35e-05	0.00206	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.34e-05	0.00204	CbGpPWpGaD
Diflunisal—TTR—Disease—JUNB—systemic lupus erythematosus	1.34e-05	0.00203	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CSK—systemic lupus erythematosus	1.31e-05	0.00198	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.3e-05	0.00198	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.27e-05	0.00193	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.24e-05	0.00188	CbGpPWpGaD
Diflunisal—TTR—Disease—PRL—systemic lupus erythematosus	1.23e-05	0.00187	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.23e-05	0.00186	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.22e-05	0.00185	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.21e-05	0.00184	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	1.21e-05	0.00184	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.21e-05	0.00184	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.19e-05	0.00182	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LYN—systemic lupus erythematosus	1.19e-05	0.0018	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.18e-05	0.0018	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.16e-05	0.00177	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.16e-05	0.00176	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	1.15e-05	0.00175	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—F3—systemic lupus erythematosus	1.14e-05	0.00173	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.07e-05	0.00163	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.07e-05	0.00163	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.05e-05	0.0016	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.03e-05	0.00156	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	9.95e-06	0.00151	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	9.94e-06	0.00151	CbGpPWpGaD
Diflunisal—TTR—Disease—JAK1—systemic lupus erythematosus	9.86e-06	0.0015	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	9.85e-06	0.0015	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	9.85e-06	0.0015	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	9.83e-06	0.00149	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	9.77e-06	0.00148	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	9.67e-06	0.00147	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.59e-06	0.00146	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.55e-06	0.00145	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	9.39e-06	0.00143	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	9.39e-06	0.00143	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JUNB—systemic lupus erythematosus	9.37e-06	0.00142	CbGpPWpGaD
Diflunisal—TTR—Disease—CCR5—systemic lupus erythematosus	9.34e-06	0.00142	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SELE—systemic lupus erythematosus	9.16e-06	0.00139	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CSK—systemic lupus erythematosus	9.16e-06	0.00139	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	9.04e-06	0.00137	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.9e-06	0.00135	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	8.77e-06	0.00133	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PPARG—systemic lupus erythematosus	8.7e-06	0.00132	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PRL—systemic lupus erythematosus	8.63e-06	0.00131	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	8.62e-06	0.00131	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	8.61e-06	0.00131	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—LYN—systemic lupus erythematosus	8.32e-06	0.00126	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	8.19e-06	0.00125	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.16e-06	0.00124	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	8.16e-06	0.00124	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	7.95e-06	0.00121	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—systemic lupus erythematosus	7.83e-06	0.00119	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	7.82e-06	0.00119	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	7.81e-06	0.00119	CbGpPWpGaD
Diflunisal—TTR—Disease—CD80—systemic lupus erythematosus	7.69e-06	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	7.65e-06	0.00116	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	7.64e-06	0.00116	CbGpPWpGaD
Diflunisal—PTGS2—Disease—XRCC6—systemic lupus erythematosus	7.63e-06	0.00116	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NOS3—systemic lupus erythematosus	7.49e-06	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.3e-06	0.00111	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAK1—systemic lupus erythematosus	6.91e-06	0.00105	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—systemic lupus erythematosus	6.85e-06	0.00104	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.74e-06	0.00102	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCR5—systemic lupus erythematosus	6.54e-06	0.000995	CbGpPWpGaD
Diflunisal—TTR—Disease—TYK2—systemic lupus erythematosus	6.49e-06	0.000986	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	6.48e-06	0.000986	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.48e-06	0.000985	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.45e-06	0.00098	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	6.41e-06	0.000974	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.41e-06	0.000974	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—C3—systemic lupus erythematosus	6.39e-06	0.000972	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS3—systemic lupus erythematosus	6.37e-06	0.000968	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.31e-06	0.00096	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	6.24e-06	0.000949	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	6.17e-06	0.000938	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.07e-06	0.000923	CbGpPWpGaD
Diflunisal—TTR—Disease—CD4—systemic lupus erythematosus	5.87e-06	0.000892	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—systemic lupus erythematosus	5.83e-06	0.000885	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—EP300—systemic lupus erythematosus	5.69e-06	0.000865	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	5.62e-06	0.000854	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—F2—systemic lupus erythematosus	5.61e-06	0.000853	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.57e-06	0.000847	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1B—systemic lupus erythematosus	5.52e-06	0.000839	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CSK—systemic lupus erythematosus	5.48e-06	0.000833	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.44e-06	0.000827	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CD80—systemic lupus erythematosus	5.38e-06	0.000818	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.24e-06	0.000797	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.2e-06	0.000791	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.15e-06	0.000783	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD247—systemic lupus erythematosus	5.15e-06	0.000783	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	5.15e-06	0.000782	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	5.14e-06	0.000782	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1A—systemic lupus erythematosus	5.09e-06	0.000774	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NCF2—systemic lupus erythematosus	5.01e-06	0.000762	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCL2—systemic lupus erythematosus	5e-06	0.000761	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.98e-06	0.000758	CbGpPWpGaD
Diflunisal—TTR—Disease—EP300—systemic lupus erythematosus	4.84e-06	0.000736	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—JAK1—systemic lupus erythematosus	4.84e-06	0.000736	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.63e-06	0.000704	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TYK2—systemic lupus erythematosus	4.54e-06	0.000691	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	4.52e-06	0.000687	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOS3—systemic lupus erythematosus	4.46e-06	0.000678	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.37e-06	0.000664	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—systemic lupus erythematosus	4.21e-06	0.00064	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAT2—systemic lupus erythematosus	4.16e-06	0.000633	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.09e-06	0.000622	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.05e-06	0.000616	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	4.01e-06	0.00061	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—F2—systemic lupus erythematosus	3.94e-06	0.000598	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JUNB—systemic lupus erythematosus	3.93e-06	0.000598	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.86e-06	0.000587	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—systemic lupus erythematosus	3.78e-06	0.000575	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.68e-06	0.000559	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	3.64e-06	0.000553	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRL—systemic lupus erythematosus	3.62e-06	0.000551	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—systemic lupus erythematosus	3.58e-06	0.000544	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.57e-06	0.000542	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—systemic lupus erythematosus	3.39e-06	0.000516	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.37e-06	0.000512	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.31e-06	0.000503	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.21e-06	0.000488	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—systemic lupus erythematosus	3.17e-06	0.000482	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS3—systemic lupus erythematosus	3.13e-06	0.000475	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.95e-06	0.000448	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK1—systemic lupus erythematosus	2.9e-06	0.00044	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	2.89e-06	0.000439	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CCR5—systemic lupus erythematosus	2.75e-06	0.000417	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.68e-06	0.000407	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.65e-06	0.000403	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.6e-06	0.000396	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.38e-06	0.000362	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.33e-06	0.000355	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.3e-06	0.000349	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD80—systemic lupus erythematosus	2.26e-06	0.000343	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.25e-06	0.000342	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—systemic lupus erythematosus	2.22e-06	0.000338	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.17e-06	0.000329	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.07e-06	0.000314	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.06e-06	0.000314	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	1.97e-06	0.0003	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.91e-06	0.00029	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.87e-06	0.000284	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.82e-06	0.000277	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	1.81e-06	0.000274	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—systemic lupus erythematosus	1.72e-06	0.000262	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.64e-06	0.000249	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.62e-06	0.000246	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.57e-06	0.000238	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.5e-06	0.000228	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.5e-06	0.000227	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.47e-06	0.000224	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—systemic lupus erythematosus	1.42e-06	0.000216	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.27e-06	0.000193	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.24e-06	0.000188	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.19e-06	0.000181	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.16e-06	0.000176	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—systemic lupus erythematosus	9.64e-07	0.000147	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—systemic lupus erythematosus	9.32e-07	0.000142	CbGpPWpGaD
